The recent medical research funding cuts have sent shockwaves through the healthcare landscape, jeopardizing critical advancements in patient safety.With over $2 billion in federal grants from the National Institutes of Health (NIH) halted, institutions like Harvard are facing unprecedented disruptions in their research efforts.